ise baggrundsrisiko for lymfomer hos reumatoid artrit patienter med længerevarende, højaktiv, inflammatorisk sygdom, som komplicerer estimeringen af risiko.
Furthermore, there is an increased background lymphoma risk in rheumatoid arthritis patients with long-standing, highly active, inflammatory disease, which complicates the risk estimation.